Canadian Securities ExchangeThe Daily Bell

Psyence Group Inc. (CSE:PSYG) w/ Jody Aufrichtig

New Canadian Stocks

February 18, 2021Newly Listed on the CSE

(CSE:PSYG)

About This Video

Psyence Group Inc. is a newly listed public company on the Canadian Securities Exchange stock market under the symbol PSYG.

Psyence Group Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. Psyence has built and operates one of the first federally licensed commercial psilocybin cultivation and production facilities. Psyence is pioneering the use of natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences.

For more information head to: https://thecse.com/en/listings/life-sciences/psyence-group-inc

Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe

STAY CONNECTED WITH THE CSE

=============================

- PODCAST: https://blog.thecse.com/pe-podcasts/

- INSTAGRAM: https://www.instagram.com/canadianexchange/

- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange

- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/

- TWITTER: https://twitter.com/CSE_News

- BLOG: https://blog.thecse.com/

- WEBSITE: https://thecse.com/

Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.

hi welcome to an episode of newly listed i'm your host barrington miller director of issue engagement at the canadian securities exchange and today i'm here with jodi ofriktik ceo and one of the founders of science welcome to the show jody good morning barrington fantastic to be here and very proud to be part of the cse jody where are you right now well i'm i'm calling you from cape town in south

africa and of course we're a global company but right now i'm sitting in southern africa on a beautiful warm sunny day tell us a little bit about science and what you do yeah well i guess we are listed companies so first and foremost we're creating value and wealth for our shareholders but we're also making a big impact on mental health and well-being and that is using natural psychedelic

medicine and how we're doing that is well we're a life sciences company we have a federal silo southern cultivation license we operational we're global we have resources in toronto resources in jamaica in the uk australia and south africa and what we're really doing is pioneering the use of natural scientific and this is where we differ to many of our peers we don't work with synthetics and we use natural silo-salvin to for

the long-term treatments of trauma and the mental health consequences of trauma oh thank you for that jody now why did you go public well i think it was very important to us as a company that we had a strong regulatory environment regulations give our industry credibility we embrace regulations i think it improves and adds to the integrity of our industry regulations are our friends as i always tell our team

so that was quite important to us of course being public gives liquidity to our investors and my view they're not investors with just custodians of their funds but access to capital markets will also enable us to grow our business and being public brings attention and of course bringing attention brings energy to our company and that will help build our business jody and just talking with you briefly off camera and also on camera

you yourself possess a lot of energy and i'm sure that that trickles on to your team can you tell us a little bit about the team that is either with you now or helped you get to this stage sure we we have a fantastic team a very very strong team myself i'm a chartered accountant ex instant young and i've built many businesses over the last 25 years but i think and i

believe what's relevant is my cannabis journey so i was a recipient of one of the first cannabis licenses in africa and in may of 2018 i sold that operation to canopy growth and for two years i took up the reigns as managing director for africa for canopy growth where i headed up their operations i bought their facility their production their brands their value and their revenue streams and then in april of

2020 i led a management buy out and a lot of people have said have you come so far so quickly well we've actually been doing this for about three years now but it's because it's part of that business that we brought back that morphed into science so we had a big head start we had the whole x canopy africa team massive head start a team with mycologists microbiologists

pharmacists legal commercial branding the full management team were in place so that really gave us a big push to get to where we are today there's a lot of energy noise and news in and around the space what would you say is your differentiator between you and other companies in this area there's a lot of noise at the moment in this space but really what differentiates us

what differentiates us is we have a commercial federal silo sabin license we designed the facility we built the facility we've imported genetics so we're fully operational and we're currently producing sala saban mushrooms both in the mushroom format and in the truffle format so that i guess would be the first differentiating factor is we are up and running and we're federally licensed we're also a global company as i

mentioned earlier with the focus on natural products but most importantly we have a very strong part to revenue and value creation for our shareholders and that is through through a number of channels supplying gmp certified silo sovereign worldwide to legalize clinics and institutions conducting clinical research of course we have a very strong medical team as well led by dr amzar neurologist and dr grant has a phd in pharmaceutical

science and dr dingle spence is a clinical oncologist so we're also using our product for our own clinical research in addition we're developing the standardized micro dose we're developing the gold standard and developing a lot of rp around dosage and delivery both for our own product or for white labeling and in addition we have another revenue stream quarter two this year we're launching a functional mushroom product which is a proprietary

blend and that will be in store in south africa followed by europe in quarter two of this year and we also have a clinic licensed pending so i guess a big differentiator in fact is we have four distinct parts to revenue sort of last but not least what do current investors and soon-to-be investors have to look forward to as far as milestones with science sure lots of exciting news coming in the

next couple of months there's going to be news around our first exports but to toronto to the uk to jamaica there'll be some interesting news about a joint venture with a number of clinics that we're working on some news around the scaling up of our production our production facility we have built can absolutely service a global market so we'll be scaling that up to meet market demand quarter two of this year there'll be

news around our functional mushroom launch and there was some news two three days ago about the commencement of some observational studies studies but there'll be some very interesting news around the commencement of our clinical trials and our micro dose product developments what's your endgame what is science's endgame what's the goal that you want this company to do i've thought long and hard about this and we certainly are yet to create shareholder

wealth and growth for our shareholders and value but at the end of the day if i can give a little girl or a little boy a mom or their dad who's alive by virtue of the work that we've done in treating their mental health then i've achieved my objective well jody on behalf of the canadian securities exchange we wish you nothing but continued success future growth and we want to thank you

for taking the time to speak with us and also for your listing for our listeners it is spelled p s y not not sci so check them out on the canadian securities exchange i've been your host barrington miller this has been an episode of newly listed thank you so much thank you for tuning in to another newly listed on the csc please feel free to hit like and share

this content and hit subscribe if you haven't already

More Newly Listed on the CSE

See them all

Tiger Financial (CSE:BANQ)From Cash to DigitalOct 27, 2026
Caldwell-Lazard CorePlus Infrastructure Fund (CSE:CPIF)Sep 14, 2026
SECUR3D Holdings (CSE:SRD)AI-Powered Brand ProtectionSep 8, 2026
Secur3D Holdings (CSE:SRD)AI-Powered Brand & IP ProtectionAug 20, 2026